# BECTON, DICKINSON AND COMPANY (BDX) FY2025 Annual P&L / Income Statement

- Company: BECTON, DICKINSON AND COMPANY (BDX)
- Period: 2024-10-01 to 2025-09-30
- Filing: FY2025 10-K, filed 2025-11-25, accession number 0000010795-25-000099
- Page: https://plicit.ai/financials/bdx/fy2025-annual-income-statement
- Chart image: https://plicit.ai/charts/bdx-fy2025-annual-income-statement-sankey.png

## Chart details: Revenue by Business Segment

Income statement for 2024-10-01 through 2025-09-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenues**: 21,840,000,000 US dollars
- **Cost of products sold**: 11,915,000,000 US dollars
- **Gross profit (calculated)**: 9,925,000,000 US dollars
- **Operating expenses (calculated)**: 7,346,000,000 US dollars
- **Operating Income**: 2,579,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 698,000,000 US dollars
- **Income from Continuing Operations Before Income Taxes**: 1,881,000,000 US dollars
- **Income tax provision**: 203,000,000 US dollars
- **Net Income**: 1,678,000,000 US dollars
- **Medical**: 11,456,000,000 US dollars
- **Life Sciences**: 5,167,000,000 US dollars
- **Interventional**: 5,217,000,000 US dollars
- **Selling and administrative expense**: 5,278,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Research and development expense**: 1,265,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Integration, restructuring and transaction expense**: 408,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Other operating expense (income), net**: 396,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Loss from Discontinued Operations, Net of Tax**: 0 US dollars. Reported below-tax contribution to net income.
- **Medical costs (calculated)**: 7,316,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Life Sciences costs (calculated)**: 3,526,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Interventional costs (calculated)**: 2,964,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Reconciling items (calculated)**: 5,455,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.

## Chart details: Revenue by Geography (2 categories)

- Page: https://plicit.ai/financials/bdx/fy2025-annual-income-statement/revenue-by-geography-2-categories
- Chart image: https://plicit.ai/charts/bdx-fy2025-annual-revenue-by-geography-2-categories-sankey.png

Income statement for 2024-10-01 through 2025-09-30. View: Geography (2 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenues**: 21,840,000,000 US dollars
- **Cost of products sold**: 11,915,000,000 US dollars
- **Gross profit (calculated)**: 9,925,000,000 US dollars
- **Operating expenses (calculated)**: 7,346,000,000 US dollars
- **Operating Income**: 2,579,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 698,000,000 US dollars
- **Income from Continuing Operations Before Income Taxes**: 1,881,000,000 US dollars
- **Income tax provision**: 203,000,000 US dollars
- **Net Income**: 1,678,000,000 US dollars
- **UNITED STATES**: 12,790,000,000 US dollars
- **International**: 9,049,000,000 US dollars
- **Undisclosed (calculated)**: 1,000,000 US dollars
- **Selling and administrative expense**: 5,278,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Research and development expense**: 1,265,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Integration, restructuring and transaction expense**: 408,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Other operating expense (income), net**: 396,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Loss from Discontinued Operations, Net of Tax**: 0 US dollars. Reported below-tax contribution to net income.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.

## Chart details: Revenue by Geography (4 categories)

- Page: https://plicit.ai/financials/bdx/fy2025-annual-income-statement/revenue-by-geography-4-categories
- Chart image: https://plicit.ai/charts/bdx-fy2025-annual-revenue-by-geography-4-categories-sankey.png

Income statement for 2024-10-01 through 2025-09-30. View: Geography (4 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenues**: 21,840,000,000 US dollars
- **Cost of products sold**: 11,915,000,000 US dollars
- **Gross profit (calculated)**: 9,925,000,000 US dollars
- **Operating expenses (calculated)**: 7,346,000,000 US dollars
- **Operating Income**: 2,579,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 698,000,000 US dollars
- **Income from Continuing Operations Before Income Taxes**: 1,881,000,000 US dollars
- **Income tax provision**: 203,000,000 US dollars
- **Net Income**: 1,678,000,000 US dollars
- **UNITED STATES**: 12,790,000,000 US dollars
- **EMEA**: 4,729,000,000 US dollars
- **Greater Asia**: 3,093,000,000 US dollars
- **Other**: 1,227,000,000 US dollars
- **Undisclosed (calculated)**: 1,000,000 US dollars
- **Selling and administrative expense**: 5,278,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Research and development expense**: 1,265,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Integration, restructuring and transaction expense**: 408,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Other operating expense (income), net**: 396,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Loss from Discontinued Operations, Net of Tax**: 0 US dollars. Reported below-tax contribution to net income.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.